US7521197B2
(en)
|
1998-06-05 |
2009-04-21 |
Alexis Biotech Limited |
Method for producing cytotoxic T-cells
|
US7264965B2
(en)
|
1998-06-05 |
2007-09-04 |
Alexis Biotech Limited |
Method for producing or enhancing a T-cell response against a target cell using a complex comprising an HLA class I molecule and an attaching means
|
GB2339782A
(en)
*
|
1998-06-05 |
2000-02-09 |
Philip Michael Savage |
Chimeric protein complexes comprising HLA class I antigens
|
FR2798128B1
(fr)
*
|
1999-09-06 |
2001-11-16 |
Inst Nat Sante Rech Med |
Moyens de detection et de purification de populations lymphocytaires t cd8+ specifiques de peptides presentes dans le contexte hla
|
US20040209314A1
(en)
|
1999-09-06 |
2004-10-21 |
Institut National De La Sante Et De La Recherche Medicale France |
Means for detection and purification of CD8+ T lymphocyte populations specific to peptides presented in the context of HLA
|
EP2316950A1
(de)
*
|
2000-03-27 |
2011-05-04 |
Technion Research and Development Foundation, Ltd. |
Einkettige Haupthistokompatibilitätskomplexe der Klasse I (MHC-I), kodierende Konstrukte und Methoden ihrer Erzeugung
|
US20040191260A1
(en)
|
2003-03-26 |
2004-09-30 |
Technion Research & Development Foundation Ltd. |
Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
|
US8022190B2
(en)
*
|
2001-06-19 |
2011-09-20 |
Technion Research & Development Foundation Ltd. |
Immuno-molecules containing viral proteins, compositions thereof and methods of using
|
US20110045005A1
(en)
|
2001-10-19 |
2011-02-24 |
Craig Crowley |
Compositions and methods for the treatment of tumor of hematopoietic origin
|
US20090068178A1
(en)
*
|
2002-05-08 |
2009-03-12 |
Genentech, Inc. |
Compositions and Methods for the Treatment of Tumor of Hematopoietic Origin
|
US9809654B2
(en)
|
2002-09-27 |
2017-11-07 |
Vaccinex, Inc. |
Targeted CD1d molecules
|
AU2003284162A1
(en)
*
|
2002-10-28 |
2004-05-25 |
Genzyme Corporation |
Anti-hiv (sl9) compounds
|
US20050025771A1
(en)
*
|
2003-03-04 |
2005-02-03 |
Greenville Hospital System |
Antitumor agents comprising a targeting portion and an immune response triggering portion
|
US20040210037A1
(en)
*
|
2003-03-28 |
2004-10-21 |
Vaccinex, Inc. |
Targeted MHC class I alpha3 vaccine delivery systems
|
US20050042218A1
(en)
*
|
2003-07-10 |
2005-02-24 |
Vaccinex, Inc. |
MHC class I - peptide-antibody conjugates with modified beta2-microglobulin
|
US9090673B2
(en)
|
2003-12-12 |
2015-07-28 |
City Of Hope |
Synthetic conjugate of CpG DNA and T-help/CTL peptide
|
US20100111856A1
(en)
|
2004-09-23 |
2010-05-06 |
Herman Gill |
Zirconium-radiolabeled, cysteine engineered antibody conjugates
|
RU2412947C2
(ru)
*
|
2004-09-23 |
2011-02-27 |
Дженентек, Инк. |
Антитела, сконструированные на основе цистеинов, и их конъюгаты
|
WO2007085266A1
(en)
*
|
2006-01-30 |
2007-08-02 |
Dako Denmark A/S |
High-speed quantification of antigen specific t-cells in whole blood by flow cytometry
|
EP2007428A2
(de)
|
2006-04-05 |
2008-12-31 |
Genentech, Inc. |
Verfahren zur verwendung von boc/cdo zur modulation der hedgehog-signalisierung
|
CA2652538C
(en)
*
|
2006-05-19 |
2016-06-28 |
Teva Pharmaceutical Industries, Ltd. |
Fusion proteins, uses thereof and processes for producing same
|
GB2442048B
(en)
*
|
2006-07-25 |
2009-09-30 |
Proimmune Ltd |
Biotinylated MHC complexes and their uses
|
US8617531B2
(en)
*
|
2006-12-14 |
2013-12-31 |
Bolder Biotechnology, Inc. |
Methods of making proteins and peptides containing a single free cysteine
|
EP2112930B1
(de)
*
|
2007-02-21 |
2017-01-11 |
Vaccinex, Inc. |
Modulation der nkt-zellaktivität mit antigenbeladenen cdid-molekülen
|
EP2155782A2
(de)
|
2007-03-26 |
2010-02-24 |
Dako Denmark A/S |
Mhc-peptid-komplexe und anwendungen davon bei infektionskrankheiten
|
EP2167537A2
(de)
|
2007-07-03 |
2010-03-31 |
Dako Denmark A/S |
Zusammengestellte verfahren für die analyse und sortierung von proben
|
AU2008276128B2
(en)
|
2007-07-16 |
2013-10-10 |
Genentech, Inc. |
Humanized anti-CD79b antibodies and immunoconjugates and methods of use
|
CL2008002085A1
(es)
|
2007-07-16 |
2008-11-21 |
Genentech Inc |
Anticuerpo humanizado anti-cd79b/igbeta/b29; polinucleotido codificacnte, vector, celula huesped; metodo de fabricacion; inmunoconjugado; composicion farmaceutica; uso para tratar cancer; metodo in vitro para determinar presencia de cd79b, oinhibir crecimiento de celulas quqe expresa cd79b; ensayo in vitro para detectar celulas b
|
EP2197908A2
(de)
|
2007-09-27 |
2010-06-23 |
Dako Denmark A/S |
Mhc-multimere in tuberkulose-diagnostika, -impfstoff und therapeutika
|
WO2009052249A1
(en)
*
|
2007-10-19 |
2009-04-23 |
Genentech, Inc. |
Cysteine engineered anti-tenb2 antibodies and antibody drug conjugates
|
CA2711736A1
(en)
|
2008-01-18 |
2009-07-23 |
Medimmune, Llc |
Cysteine engineered antibodies for site-specific conjugation
|
HUE029869T2
(en)
*
|
2008-01-31 |
2017-04-28 |
Genentech Inc |
Anti-CD79B antibodies and immunoconjugates, as well as application procedures
|
US10968269B1
(en)
|
2008-02-28 |
2021-04-06 |
Agilent Technologies, Inc. |
MHC multimers in borrelia diagnostics and disease
|
WO2010009735A2
(en)
*
|
2008-07-23 |
2010-01-28 |
Dako Denmark A/S |
Combinatorial analysis and repair
|
GB0817244D0
(en)
*
|
2008-09-20 |
2008-10-29 |
Univ Cardiff |
Use of a protein kinase inhibitor to detect immune cells, such as T cells
|
US11992518B2
(en)
|
2008-10-02 |
2024-05-28 |
Agilent Technologies, Inc. |
Molecular vaccines for infectious disease
|
WO2010037402A1
(en)
|
2008-10-02 |
2010-04-08 |
Dako Denmark A/S |
Molecular vaccines for infectious disease
|
KR101928684B1
(ko)
|
2009-01-08 |
2018-12-12 |
앨버트 아인슈타인 컬리지 오브 메디신, 인크. |
세포벽 결합 세라미드 유사 당지질을 갖는 박테리아 백신 및 이의 용도
|
WO2010106535A1
(en)
|
2009-03-15 |
2010-09-23 |
Technion Research And Development Foundation Ltd. |
Soluble hla complexes for use in disease diagnosis
|
CN102471380B
(zh)
|
2009-04-01 |
2015-01-14 |
霍夫曼-拉罗奇有限公司 |
抗FcRH5抗体和免疫偶联物及使用方法
|
CA2756988A1
(en)
|
2009-04-01 |
2010-10-07 |
Genentech, Inc. |
Anti-fcrh5 antibodies and immunoconjugates
|
EP2711018A1
(de)
|
2009-06-22 |
2014-03-26 |
MedImmune, LLC |
Manipulierte Fc-Regionen für standortspezifische Konjugation
|
TWI537383B
(zh)
|
2009-11-30 |
2016-06-11 |
建南德克公司 |
診斷及治療腫瘤之組合物及方法
|
SG183335A1
(en)
|
2010-02-23 |
2012-09-27 |
Genentech Inc |
Compositions and methods for the diagnosis and treatment of tumor
|
EP3372617B1
(de)
|
2010-04-02 |
2024-07-24 |
Amunix Pharmaceuticals, Inc. |
Bindungsfusionsproteine, bindungsfusionsproteinarzneimittelkonjugate, xten-arzneimittelkonjugate sowie verfahren zur herstellung und verwendung davon
|
SG185027A1
(en)
|
2010-05-03 |
2012-11-29 |
Genentech Inc |
Compositions and methods for the diagnosis and treatment of tumor
|
WO2011146568A1
(en)
|
2010-05-19 |
2011-11-24 |
Genentech, Inc. |
Predicting response to a her inhibitor
|
CN114246952A
(zh)
|
2010-06-08 |
2022-03-29 |
基因泰克公司 |
半胱氨酸改造的抗体和偶联物
|
EP3406347A3
(de)
|
2012-02-27 |
2019-02-13 |
Amunix Operating Inc. |
Xten-konjugat-zusammensetzungen und verfahren zur herstellung davon
|
US9371352B2
(en)
|
2013-02-08 |
2016-06-21 |
Vaccinex, Inc. |
Modified glycolipids and methods of making and using the same
|
AR096687A1
(es)
|
2013-06-24 |
2016-01-27 |
Genentech Inc |
Anticuerpos anti-fcrh5
|
RS60453B1
(sr)
|
2013-12-17 |
2020-07-31 |
Genentech Inc |
Anti-cd3 antitela i postupci upotrebe
|
EP3388449A3
(de)
|
2014-09-12 |
2018-10-24 |
F. Hoffmann-La Roche AG |
Cystein-manipulierte antikörper und konjugate
|
RS60349B8
(sr)
|
2014-09-23 |
2022-10-31 |
Hoffmann La Roche |
Postupak upotrebe anti-cd79b imunokonjugata
|
CN107849132B
(zh)
|
2015-06-16 |
2022-03-08 |
豪夫迈·罗氏有限公司 |
人源化的和亲和力成熟的针对FcRH5的抗体和使用方法
|
MA44334A
(fr)
|
2015-10-29 |
2018-09-05 |
Novartis Ag |
Conjugués d'anticorps comprenant un agoniste du récepteur de type toll
|
EP3497121A2
(de)
*
|
2016-08-11 |
2019-06-19 |
Kite Pharma Eu B.V. |
Verfahren zur herstellung und verwendung von löslichen mhc-molekülen
|
US10294454B2
(en)
|
2016-08-24 |
2019-05-21 |
General Electric Company |
Methods and kits for cell activation
|
EP3719033A1
(de)
*
|
2019-04-02 |
2020-10-07 |
imusyn GmbH & Co. KG |
Stabilisiertes mhc i
|
US20220273810A1
(en)
|
2019-07-08 |
2022-09-01 |
Imcare Biotech, Llc |
Anti-serine protease inhibitor kazal (spik) antibodies, immunoconjugates, and methods of use
|
CN114901699A
(zh)
|
2019-09-11 |
2022-08-12 |
英凯尔生物科技有限责任公司 |
抗丝氨酸蛋白酶抑制剂kazal(spik)抗体的表位
|
BR112022011824A2
(pt)
|
2019-12-18 |
2022-08-30 |
Teneofour Inc |
Anticorpos de cadeia pesada que se ligam a cd38
|
WO2022271987A1
(en)
|
2021-06-23 |
2022-12-29 |
TeneoFour, Inc. |
Anti-cd38 antibodies and epitopes of same
|